No Picture
Trading Ideas

Japanese hotel group Unizo gets six new buyout offers

Japanese hotel operator Unizo Holdings said on Sunday it had received six more buyout offers at a price competitive with an existing $1.6 billion bid proposed by Blackstone Group. Unizo said it had received offers from four overseas investment funds and one Japanese fund as well as one domestic company, without naming the bidders. Unizo said none of the offers would meet its demands. …read more […]

No Picture
Trading Ideas

Amazon to open store on China's Pinduoduo marketplace on Nov. 25 – source

Amazon.com Inc will open a store on Chinese e-commerce platform Pinduoduo on Monday, a source familiar with the matter said, in a sign of how the U.S. firm’s China strategy is evolving after it shut its own online store in the country. Amazon closed its Chinese marketplace in July, having found it difficult to gain traction in the face of intense competition from entrenched, home-grown rivals like Alibaba Group Holding’s Tmall marketplace and JD.com. It said at the time it would increase its focus on selling goods from abroad to Chinese buyers via its global platform. …read more […]

No Picture
Trading Ideas

France's LVMH nears deal to buy U.S. jewelry chain Tiffany for about $16.3 billion – sources

Bulgari owner LVMH is nearing a deal to acquire Tiffany for $135 per share, the sources said, adding that a deal could be announced either on Sunday or Monday. Reuters reported this week that LVMH had persuaded Tiffany to provide it with confidential due diligence after it raised its bid to close to $16 billion. Tiffany earlier this month rebuffed LVMH’s initial $120-per-share all-cash offer, arguing it significantly undervalued the company. …read more […]

No Picture
Trading Ideas

Novartis Nears Deal to Buy Medicines Co. for $85/Share: WSJ

(Bloomberg) — Novartis AG is close to a deal to buy Medicines Co., the developer of a promising cholesterol drug, for $85 a share, according to news reports.An agreement could be announced today, according to the Wall Street Journal, which assigned a $7 billion price tag to the deal. Umer Raffat, an analyst at Evercore ISI, put the transaction value at $9.1 billion when taking the fully diluted shares into account.The Swiss drugmaker has been conducting due diligence on the Parsippany, New Jersey-based company, Bloomberg reported last week. At $85 a share, Novartis would be paying about a 45% premium …read more […]